Chi Sheng Pharma & Biotech , Ltd Current Cash

Chi Sheng Pharma & Biotech , Ltd posts a current cash of $470M as of June 2026. That compares with $320M in the prior-year period — up 46.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Chi Sheng Pharma & Biotech , Ltd's current cash was $320M. The latest reading is $470M — a 46.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Chi Sheng Pharma & Biotech , Ltd's financial statement story. At $470M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4111.TWO's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Chi Sheng Pharma & Biotech , Ltd's other metric pages and overview cover the third.